孕晚期产前抗生素治疗无乳链球菌感染对新生儿的影响

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (790 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of prenatal antibiotic treatment on neonates whose mothers tested positive with streptococcus lactis in the third trimester of pregnancy and the related indexes of septicemia detection in high-risk newborns.Methods A total of 105 high-risk newborns born to pregnant women with positive GBS screening in the neonatal ward of the Fifth Medical Center of the PLA General Hospital were selected between January 2017 and December 2019. According to whether prenatal intravenous antibiotics were used, these newborns were divided into the antibiotic group (n=45) and control group (n=60) 2 ml venous blood was collected from each newborn in the two groups for routine blood detection at 6, 24, 72 h after birth and for PCT detection at 72 h after birth. After admission, newborns whose levels of leukocytes or CRP tested abnormal for the first time were treated with penicillin. Blood culture tests were completed prior to antibiotic use.Results There was no significant difference in the white blood cell count at 6, 24 and 72 hours after birth between the two groups. Levels of CRP measured at 24 and 72 hours after birth were higher in the control group than in the antibiotic group (P<0.05). There was no difference in levels of PCT measured 72 hours after birth between the two groups. In the control group, there were 2 cases of neonatal septicaemia (GBS was detected in blood culture) and 7 cases of clinically diagnosed septicaemia. In the antibiotic group, there was one case of streptococcus agalactiae septicaemia (GBS was detected in blood culture). The incidence of sepsis in the control group was significantly higher than that of the antibiotic group [2.2% vs.15.0%,χ²=4.872,P=0.027].Conclusions If pregnant women with positive GBS screening receive no antibiotic treatment before delivery, the chance of neonatal septicemia is significantly increased. CRP can be used as an indicator of sepsis in high-risk neonates born to pregnant women with positive GBS screening in the third trimester.

Key words： streptococcus agalactiae group B streptococcus routine blood C-reactive protein procaicitonin antibiotics sepsis

Received: 20 July 2020

ZTFLH:

R446.5

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Jingwen
	ZHANG Xuefeng

Cite this article:

ZHU Jingwen,ZHANG Xuefeng. Influence of prenatal antibiotic treatment of streptococcus agalactiae infection in late pregnancy on neonates[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(2): 100-104.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2021/V32/I2/100

[1]	王莹超,陆文香,周莉婧. 新生儿无乳链球菌感染的危险因素及药敏分析[J].国际检验医学杂志,2015,36(8):1065-1066.
[2]	Kwatra G,Cunnington M C,Merrall E, et al. Prevalence of maternal colonisation with group B streptococcus:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2016, 16(9):1076-1084.
[3]	王真真,卢丹,蒋敏. 围生期B族链球菌感染的诊治及其疫苗研究[J].中华妇幼临床医学杂志(电子版),2019,15(1):98-101.
[4]	杨林东,杨露,孙丽洲.围生期新生儿不同血清型B族链球菌感染及其预防研究现状 [J/CD].中华妇幼临床医学杂志(电子版),2017,13(6):621-626.
[5]	Schrag S J, Verani J R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: exexperience in the United States and implycations for a potential group B streptococcal vaccine[J].Vaccine, 2013, 31(4): D20-D26.
[6]	吴丽娟,王飞玲,邹建话,等.妊娠晚期B族链球菌筛查对妊娠结局的影响[J].中华妇产科杂志,2019,54(3):154-159.
[7]	黄翔,林创廷.血清CRP、PCT的检测在新生儿败血症中的诊断价值研究[J].中国当代医药,2017,24(20):92-93.
[8]	吴银弟,许平,王丹.新生儿感染的临床诊断[J].中国综合临床,20l4,30(13):95.
[9]	刘云峰,童笑梅,郑方圆,等.早产儿生后早期血清降钙素原生理变化规律的研究[J].中国当代儿科杂志,2013,15(2):81-84.
[10]	邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M].北京:人民卫生出版社,2019:512-513.
[11]	王涛,陈红,杨军,等.β-溶血的链球菌与未足月胎膜早破的关系及母儿预后[J].四川医学,2011,32(9):1383-1384.
[12]	Le D K, Heath P T. An overview of global GBS epidemiology[J].Vaccine,2013,31(suppl 4): D7-D12.
[13]	Lu B, Li D, Cui Y, et al. Epidemiology of Group B streptococcus isolated from pregnant women in beijing,China[J]. Clin Microbiol Infect, 2014, 20(6): 370-373.
[14]	胡发龙.孕晚期妇女无乳链球菌感染与耐药性情况及对新生儿的影响[J].中国微生态学杂志,2016, 28(5):598-600.
[15]	张梅娟,卢洪萍,袁天明,等.妊娠晚期B族溶血性链球菌带菌状况对产妇和新生儿的影响[J].中华新生儿科杂志,2017,32(5):365-367.
[16]	秦利,张利侠,袁军,等.孕妇生殖道B族链球菌感染与胎膜早破的关系及其对母儿预后的影响[J].国际检验医学杂志,2013,34(8):928-929.
[17]	梅艳,张萍,金敏菲,等.妊娠相关B族链球菌感染的研究进展[J].中华围产医学杂志,2017,20(12):895-898.
[18]	King L, Silverman N S, Turrentine M. Prevention of group B streptococcal early-onset disease in newborns[J]. Obstet Gynecol, 2019, 134(1):e19-22.
[19]	赵丽娟,李合欣,高爱梅,等.孕妇生殖道B族链球菌定植及分娩期抗生素干预对妊娠结局的影响[J].中国药物与临床,2019,19(12):2012-2013.
[20]	李樉,杨慧霞.我国围产期B族链球菌感染的现状及筛查策略[J].中华围产医学杂志,2017,20(8):560-563.
[21]	林新祝,吴健宁,张雪芹,等.晚孕期阴道B族链球菌定植与新生儿感染的关系[J].中华围产医学杂志,2016,19(7):491-496.
[22]	Sass L. Group B streptococcal infections[J]. Pediatr Rev,2012,33(5):219-225.
[23]	孙东明,董巧丽,杨小巍,等.降钙素原及超敏C反应蛋白在新生儿败血症早期诊断中的临床价值研究[J].现代预防医学,2012,39(9):2169-2170.
[24]	Phares C R, Lynfield R, Farley M M, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Active bacterial core surveillance/emerging infections programnetwork[J]. JAMA, 2008, 299(20):56-65.
[25]	张洪福,邱振华,车伟坤,等.PCT、CRP 及 WBC 检测对新生儿感染诊断的价值[J].国际检验医学杂志,2016,37(13):1872-1873.